PExA AB (publ) (PEXA-B.ST)
Stockholm · SEK · Healthcare · Medical Devices
SEK 0.315 (+1.94%) as of
Key statistics
- Market cap
- 64.93M
- EPS (TTM)
- -0.0500
- Dividend yield
- 0.00%
- 52-week range
- 0.1700 – 0.8340
- Beta
- 1.24
- Revenue (TTM)
- 1.35M
- Profit margin
- -286.81%
- Volume
- 28.02k
About PExA AB (publ)
PExA AB (publ) develops and commercializes diagnostic products for various respiratory diseases. It offers products for asthma, tuberculosis, cystic fibrosis, lung cancer, and chronic obstructive pulmonary disease. The company's research instrument helps lung researchers in the collection of microscopic particles and biomarkers for diseases in the small airways. It offers PExA 2.0, an instrument for the non-invasive collection of particles in exhaled air. The company also provides accessories, which include substrate surfaces and nozzles, as well as parts and service kits. It provides products for lung research centers within the health services, academia, and pharmaceutical companies. The company was founded in 2004 and is based in Gothenburg, Sweden.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Gothenburg, Sweden
- Employees
- 3
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.